OnKure Therapeutics Inc.
OKUR | NASDAQ
$3.08
+$0.02 (+0.65%)
Sep 22, 2026, 1:03 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 830K | n/a | n/a | n/a | 50K | 37K |
Gross Profit | -830K | n/a | n/a | n/a | -50K | -37K |
Operating Income | -62.95M | -54.39M | -36.93M | -29.77M | -39.82M | -19.55M |
Interest Income | 3.44M | 2.01M | 1.62M | 254K | n/a | n/a |
Pretax Income | -59.52M | -52.67M | -35.31M | -29.51M | -39.77M | -19.47M |
Net Income | -59.52M | -52.67M | -35.31M | -29.51M | -39.77M | -19.47M |
Selling & General & Admin | 14.69M | 10.59M | 4.82M | 3.9M | 11.65M | 3.61M |
Research & Development | 48.26M | 43.8M | 32.12M | 25.86M | 28.12M | 15.91M |
Other Expenses | -830K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 62.12M | 54.39M | 36.93M | 29.77M | 39.77M | 19.52M |
Interest Expense | n/a | 300K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 62.95M | 54.39M | 36.93M | 29.77M | 39.82M | 19.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 13.52M | 13.34M | 13.34M | 13.34M | 1.81M | 2.51M |
Shares Outstanding (Diluted) | 13.52M | 13.34M | 13.34M | 13.34M | 1.81M | 2.51M |
EPS (Basic) | -4.40 | -3.95 | -2.65 | -2.21 | -21.92 | -7.74 |
EPS (Diluted) | -4.40 | -3.95 | -2.65 | -2.21 | -21.92 | -7.74 |
EBITDA | -58.69M | -51.71M | -34.75M | -29.13M | -39.72M | -19.43M |
EBIT | -59.52M | -52.37M | -35.31M | -29.51M | -39.77M | -19.47M |
Depreciation & Amortization | 830K | 662K | 560K | 387K | 50K | 37K |
Add to Watchlist
Select watchlists to add or remove OKUR